“The Transfusion Medicine Service in the Department of Pathology performs therapeutic apheresis on patients who have an illness associated with an abnormal cellular or plasma-based blood component,” ...
Global Apheresis Market to Grow at 8% CAGR Driven by Chronic Disease Burden and Blood Demand by 2030
The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven by the increasing prevalence of chronic and autoimmune diseases, growing ...
Ever since she first experienced such hallmark COVID-19 symptoms as fever, shortness of breath, and muscle pain, in March 2020, 39-year-old Miriam has continued to suffer. In 2021, her health ...
The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven by the increasing prevalence of chronic and autoimmune diseases, growing ...
Jeffrey Frist was getting desperate. Diagnosed with familial hypercholesterolemia (FH) in 2012 after his first heart attack the year before, he had experienced a cardiovascular event every 11 months ...
A BMJ investigation shows patients spend a lot to likely benefit little. This is a MedPage Today story. With long COVID patients becoming increasingly frustrated with the lack of available treatments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback